LeMaitre Vascular: 31% Drawdown On $0.02 Guidance Cut (NASDAQ:LMAT)

seekingalpha.com · 2026-08-13

LeMaitre Vascular stock remains a Buy after a 31% pullback. Click to see LMAT's Q2 drivers, Artegraft growth, margin upside, and valuation reset.